outcome of board meeting held on 29.05.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The board approved audited financial results for FY ended March 31, 2026. Samsrita Labs reported a standalone loss of Rs. 868.60 lakhs, a massive deterioration from Rs. 25.95 lakhs loss in the previous year - a 33x increase in losses. Revenue from operations remained flat at Rs. 181 lakhs. The company appointed M/s Tungala & Co. as internal auditors for FY 2026-27 and approved write-offs of Rs. 3.15 lakhs in sundry creditors and Rs. 2.09 crore in irrecoverable trade receivables from Mangala Savitri Bizcon Private Limited. Operating cash flow was deeply negative at Rs. 502.42 lakhs. The auditor issued an unmodified opinion with an emphasis of matter on the bad debts write-off. Share capital increased to Rs. 2,274.97 lakhs through financing activities.
The stock shows severe financial stress with losses growing 33x year-on-year, deeply negative operating cash flows, and significant asset write-offs. Shareholders should note that negative reserves of Rs. 1,141 lakhs and the Rs. 2 crore write-off from a single entity raise concerns about governance and recoverability practices.